AzurRx BioPharma Inc News - AZRX

Small Company Offering and Sale of Securities Without Registration (d)

UNITED STATES SECURITIESAND EXCHANGE COMMISSIONWashington, D.C.FORM DOMB APPROVALOMB Number: 3235-0076Estimated Average burden hours per...

Securities Registration Statement (simplified Form) (s-3)

As filed with the Securities and Exchange Commission on March 21, 2023 Registration No. 333- ...

Annual Report (10-k)

P0YP0YP0YP6Y6M662.25550.170First Wave BioPharma, Inc.0001604191--12-312022FYfalse168533689P9M99500370742631.34662.2500000000000.1016853368999500370...

Current Report Filing (8-k)

0001604191 false 0001604191 2023-03-12 2023-03-12 iso4217:USD xbrli:shares...

Current Report Filing (8-k)

0001604191 false 0001604191 2023-02-06 2023-02-06 iso4217:USD xbrli:shares...

Current Report Filing (8-k)

0001604191 false --12-31 0001604191 2023-01-13 2023-01-13 iso4217:USD...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

0001604191 false 0001604191 2022-12-20 2022-12-20 iso4217:USD xbrli:shares...

Current Report Filing (8-k)

0001604191 false 0001604191 2022-12-14 2022-12-14 iso4217:USD xbrli:shares...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:December 08, 2022...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AzurRx BioPharma Inc (AZRX)

Empower your portfolio: Real-time discussions and actionable trading ideas.

AZRX News

Small Company Offering and Sale of Securities Without Registration (d)

Securities Registration Statement (simplified Form) (s-3)

Annual Report (10-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Current Report Filing (8-k)

Notice of Effectiveness (effect)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

AZRX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AzurRx BioPharma Inc (AZRX) News

AzurRx BioPharma Inc (AZRX)

Empower your portfolio: Real-time discussions and actionable trading ideas.

AZRX News

Small Company Offering and Sale of Securities Without Registration (d)

Securities Registration Statement (simplified Form) (s-3)

Annual Report (10-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Current Report Filing (8-k)

Notice of Effectiveness (effect)

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

AZRX Discussion

Your Recent History